GIGABYTE-TECHNOLOGY
26.2.2024 09:31:26 CET | Business Wire | Press release
GIGABYTE Technology, an IT pioneer advancing global industries through cloud and AI computing systems, is presenting innovative enterprise computing solutions at MWC 2024, featuring trailblazing servers, green computing solutions, and edge AI technologies, under the theme "Future of COMPUTING." These advancements usher in new possibilities for agile and sustainable IT strategies, enabling industries to harness real-time intelligence across hyperconnected data centers, cloud, edge, and devices, resulting in enhanced efficiency, cost-effectiveness, and competitive advantages, all propelled by the synergies of 5G and AI technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226750501/en/
GIGABYTE Ignites AI and 5G Visions at MWC 2024, Highlighting New Supercomputers, Edge AI and Sustainable IT Upgrades (Photo: Business Wire)
The New Supercomputer Unveiled
GIGABYTE presents G593-ZX1/ZX2, the AI server featuring AMD Instinct™ MI300X 8-GPU, which is a new addition to GIGABYTE’s flagship AI/HPC server series. Other highlighted exhibits include the high-density H223-V10 supporting the NVIDIA Grace Hopper Superchip, the G383-R80 server supporting four AMD Instinct™ MI300A APUs, and a G593 series AI server equipped with the powerful NVIDIA HGX H100 8-GPU.
Adjacent to these trailblazing AI/HPC servers stands the all-flash array storage server, S183-SH0. With the capacity for 32 E1.S NVMe SSDs, it provides hyper-speed data storage, ideal for handling complex AI workloads such as large language models (LLM). Altogether, these servers can be integrated into the supercomputer clusters and 5G framework, serving as the cornerstone of AI-ready infrastructure and driving business and research breakthroughs at exascale.
Flexible Edge Platform for the Next Phase of 5G and AI
At the booth, GIGABYTE introduces a highly adaptable edge server, E263-S30, surrounded by a power supply and motherboard alongside NICs and accelerators from AMD, Broadcom, Intel, and NVIDIA. E263-S30 exemplifies how GIGABYTE’s modular servers cater to a wealth of IT scenarios by upgrading various hardware specifications within a unified chassis. Its flexibility proves instrumental in expediting large-scale 5G network deployments while minimizing maintenance and upgrade costs.
One-Stop Solution for Green IT Upgrades
The dissipation of excess heat from servers emerges as a notable contributor to energy waste. GIGABYTE addresses this challenge by presenting the A1P0-EB0, a large-scale 25U EIA immersion cooling tank, showcasing outstanding server heat dissipation of up to 80kW and a PUE as low as 1.02. GIGABYTE also provides an extensive range of immersion-ready servers, supporting both Intel and AMD processors, and cater to all kinds of workloads. They exemplify how GIGABYTE's comprehensive green computing solutions enable data centers to reduce power consumption and achieve a more favorable total cost of ownership (TCO).
Versatile Enterprise Servers with Robust Networking Capabilities
GIGABYTE presents a diverse server lineup designed for telecom, cloud service providers, enterprises, and SMBs, enabling the establishment of open and secure digital architectures across network environments. The Arm server, R163-P32, boasts its energy-efficient core-dense system, providing operational advantages for large-scale cloud-native workloads.
In AI workloads and edge cloud applications, the R243-EG0 and R143-EG0 servers support AMD EPYC™ 8004 Series processors, providing exceptional performance per watt and suitability for telco environments. For SMB IT solutions, GIGABYTE introduces R113-C10 and R123-X00, equipped with AMD Ryzen™ 7000 and Intel® Xeon® E-2400 processors, ensuring reliable IT operations such as web hosting, hybrid cloud, and data storage.
Highly Accurate Self-Driving Technologies Fueled by Edge AI
Integrating edge technology, AI algorithms, and cutting-edge chips, GIGABYTE's Advanced Driver Assistance Systems (ADAS) and telematics make real-time driving decisions for a safe and intelligent self-driving experience. Providing rich I/O interfaces, they seamlessly integrate with various sensing devices, including cameras, ultrasonic sensors, LiDAR, and mmWave radars, gathering comprehensive environmental data to guide vehicles along the optimal route under dynamic and challenging road conditions.
Visit GIGABYTE’s MWC event page.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226750501/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom